Evidence map›Paper›PMID 38561379›Full record

ArticleScientific reports2024

Machine learning-based survival prediction nomogram for postoperative parotid mucoepidermoid carcinoma.

Zongwei Huang, Zihan Chen, Ying Li, Ting Lin, Sunqin Cai, Wenxi Wu, Lishui Wu, Siqi Xu, Jun Lu, Sufang Qiu

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zongwei Huang *Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Zihan Chen *Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Ying LiFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Ting LinFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Sunqin CaiFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Wenxi WuFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Lishui WuFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Siqi XuFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China.
Jun LuFujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, China. lujvip@126.com.
Sufang QiuRadiation Oncology Department, Clinical Oncology School, Fujian Cancer Hospital, Fujian Medical University, Fuzhou, Fujian, China. sufangqiu@fjmu.edu.cn.ORCID 0000-0001-7660-6955

Funding

Science and Technology Program of Fujian Province, China 2018Y2003
6 · The paper itself

Abstract

Parotid mucoepidermoid carcinoma (P-MEC) is a significant histopathological subtype of salivary gland cancer with inherent heterogeneity and complexity. Existing clinical models inadequately offer personalized treatment options for patients. In response, we assessed the efficacy of four machine learning algorithms vis-à-vis traditional analysis in forecasting the overall survival (OS) of P-MEC patients. Using the SEER database, we analyzed data from 882 postoperative P-MEC patients (stages I-IVA). Single-factor Cox regression and four machine learning techniques (random forest, LASSO, XGBoost, best subset regression) were employed for variable selection. The optimal model was derived via stepwise backward regression, Akaike Information Criterion (AIC), and Area Under the Curve (AUC). Bootstrap resampling facilitated internal validation, while prediction accuracy was gauged through C-index, time-dependent ROC curve, and calibration curve. The model's clinical relevance was ascertained using decision curve analysis (DCA). The study found 3-, 5-, and 10-year OS rates of 0.887, 0.841, and 0.753, respectively. XGBoost, BSR, and LASSO stood out in predictive efficacy, identifying seven key prognostic factors including age, pathological grade, T stage, N stage, radiation therapy, chemotherapy, and marital status. A subsequent nomogram revealed a C-index of 0.8499 (3-year), 0.8557 (5-year), and 0.8375 (10-year) and AUC values of 0.8670, 0.8879, and 0.8767, respectively. The model also highlighted the clinical significance of postoperative radiotherapy across varying risk levels. Our prognostic model, grounded in machine learning, surpasses traditional models in prediction and offer superior visualization of variable importance.

Indexed as

Carcinoma, MucoepidermoidParotid NeoplasmsAlgorithmsHumansMachine LearningNomogramsMachine learningNomogramParotid mucoepidermoid carcinomaPostoperative radiotherapySEER

Identifiers

PMID38561379
PMCPMC10985107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.